Back
Akoya Biosciences Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
34
AKYA
Akoya Biosciences
Last Price:
2.35
Seasonality Move:
-5.67%
Sell
38
RARE
Ultragenyx Pharmaceutical
Last Price:
39.58
Seasonality Move:
3.65%
Sell
34
Akoya Biosciences (AKYA)
is a Sell
Is Akoya Biosciences a Buy, Sell or Hold?
- The current Akoya Biosciences [AKYA] share price is $2.23. The Score for AKYA is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- AKYA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $38.02. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AKYA Stock Price Chart
What is Akoya Biosciences's stock price today?
-
The Akoya Biosciences share price today is $2.23
The current trend is relatively stagnant and AKYA is experiencing buying pressure, which is a positive indicator for future bullish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $38.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.
AKYA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.27 | Sell |
Relative Strength Index (14 RSI): | 39.44 | Sell |
Chaikin Money Flow: | 120435 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.99 - 2.55) | Sell |
Bollinger Bands (100): | (2.88 - 5.42) | Sell |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.74 | Sell |
Relative Strength Index (14 RSI): | 40.05 | Sell |
Chaikin Money Flow: | 76134 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.06 - 42.34) | Sell |
Bollinger Bands (100): | (41.13 - 48.85) | Sell |
AKYA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.2 | Buy |
20-day SMA: | 2.14 | Buy |
50-day SMA: | 3.12 | Sell |
200-day SMA: | 4.25 | Sell |
8-day EMA: | 2.18 | Buy |
20-day EMA: | 2.34 | Sell |
50-day EMA: | 2.99 | Sell |
200-day EMA: | 4.53 | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.68 | Sell |
20-day SMA: | 40.48 | Sell |
50-day SMA: | 42.18 | Sell |
200-day SMA: | 42.45 | Sell |
8-day EMA: | 39.81 | Sell |
20-day EMA: | 40.64 | Sell |
50-day EMA: | 42.13 | Sell |
200-day EMA: | 43.5 | Sell |
Akoya Biosciences Earnings Growth & AKYA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.00 per share, an increase this year of $0.47 per share, and an increase next year of $0.32 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
Akoya Biosciences Technical Analysis
Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |